Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CCR3 | P51677 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13850082 | 0.90 | ALDH1A1 (0.60) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL26505364 | 0.89 | ALDH1A1 (0.50) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL10282362 | 0.85 | ALDH1A1 (0.54) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL22691916 | 0.82 | ALDH1A1 (0.60) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL4569260 | 0.80 | ALDH1A1 (0.48) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL22123358 | 0.80 | ALDH1A1 (0.48) | ALDH1A1PKMPOLBSMN1; SMN2TSHR | |
| SCHEMBL4500757 | 0.80 | GNAO1 (0.49) | ALDH1A1PKMMAPTTSHRGNAO1 | |
| SCHEMBL240458 | 0.80 | ALDH1A1 (0.58) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL18173166 | 0.80 | ALDH1A1 (0.58) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL15308547 | 0.76 | ALDH1A1 (0.52) | ALDH1A1PKMPOLBSMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0673782-B1 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORP (US) | 2000-06-14 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-3189091-A2 | MAIN CHAIN POLYAMINES | Genzyme Corporation (US) | 2017-07-12 | — | — | EP | disclosed |
| US-20170182087-A1 | MAIN CHAIN POLYAMINES | GENZYME CORPORATION (US) | 2017-06-29 | — | — | US | disclosed |
| WO-2016007821-A2 | MAIN CHAIN POLYAMINES | GENZYME CORPORATION (US) | 2016-01-14 | — | — | WO | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| EP-1090930-B1 | POLYMERIZATION METHOD | KANEKA CORP (JP) | 2005-05-04 | — | — | EP | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| EP-1090930-A1 | POLYMERIZATION METHOD | KANEKA CORPORATION (JP) | 2001-04-11 | — | — | EP | disclosed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | disclosed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | disclosed |
| US-6033825-A | CONTAINING A HYDRAZINE COMPOUND AND A CONTRAST-BOOSTING AMINO COMPOUND AND/OR PHOSPHONIUM COMPOUND, AND THE SILVER HALIDE EMULSION LAYER OR IN A LAYER IN A REACTIVE RELATIONSHIP THEREWITH, CONTAINS A VINYLLACTAM POLYMER | AGFA-GEVAERT NV (BE) | 2000-03-07 | — | — | US | disclosed |
| US-5622137-A | FOR USE IN TESTING COOKED FOODS | TRANS WORLD SERVICES (US) | 1997-04-22 | — | — | US | disclosed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | disclosed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170182087-A1 | MAIN CHAIN POLYAMINES | SRM, SMS, ODC1 | ALDH1A1 3155/4885PKM 1302/4885POLB 67/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.